Back to Catalog
Growth
CJC-1295/Ipamorelin
Dual Peptide ComplexPurity ≥98.0%popular
Select Amount
Quantity
1
$55.00Third-party tested
Research grade
Discreet packaging
A dual-peptide research formulation combining CJC-1295, a GHRH analog with extended half-life via Drug Affinity Complex (DAC) technology, and Ipamorelin, a highly selective ghrelin/GHS-R1a receptor agonist. Research programs examine the combined effects on GH axis stimulation — CJC-1295 sustains elevated baseline GH activity while Ipamorelin drives pulsatile GH release without significant cortisol or prolactin elevation. Studies investigate this combination for GH pulsatility patterns, IGF-1 production, and lean tissue composition research.
Research Use Only: This compound is intended solely for in vitro research and laboratory studies. It is not approved for human consumption, veterinary use, or any clinical application. Purchase is restricted to licensed researchers and institutions. By purchasing you confirm compliance with all applicable regulations.
Related Research Compounds
